What is the cause of Giant Cell Arteritis (GCA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cause of Giant Cell Arteritis

Etiology and Pathogenesis

Giant cell arteritis is a disease of unknown etiology that develops in genetically predisposed individuals over age 50, triggered by unidentified environmental factors that activate dendritic cells in the arterial wall, initiating an autoimmune cascade. 1, 2

The exact cause of GCA has not been clearly identified, but the current understanding points to a multifactorial process:

Genetic and Environmental Factors

  • Genetic predisposition plays a significant role, with the highest incidence observed in populations of Northern European descent, particularly in Scandinavian nations and Minnesota, suggesting hereditary susceptibility. 3, 4

  • Environmental triggers remain unidentified but are thought to interact with genetic factors to initiate disease in susceptible individuals. 1, 2

  • Age-related factors are critical, as advancing age represents the strongest risk factor for GCA, contributing to both immune system dysfunction (immunosenescence) and vascular system abnormalities. 5

Immunopathologic Mechanism

The disease process unfolds through a specific sequence:

  • Dendritic cell activation occurs first, with vascular dendritic cells embedded in the adventitia of normal arteries becoming activated and matured by unknown triggers. 1, 5

  • T-cell recruitment and activation follows, as activated dendritic cells produce chemokines that recruit CD4+ T cells, which then proliferate and polarize into Th1 and Th17 cells producing IFN-γ and IL-17. 1

  • Macrophage differentiation occurs when monocytes are recruited and differentiate into macrophages, which form multinucleated giant cells (the histological hallmark) when persistently exposed to IFN-γ. 6, 1

  • Vascular remodeling results from immune cells and vascular smooth muscle cells triggering arterial wall destruction, leading to intimal hyperplasia and progressive arterial lumen occlusion responsible for ischemic symptoms. 6, 1

Key Pathophysiologic Features

  • The inflammatory process is characterized by arterial wall thickening with narrowed lumen, mononuclear inflammatory cell infiltration with media invasion, and the presence of multinucleated giant cells. 6, 7

  • Both innate and adaptive immune systems contribute to granuloma formation and the development of arterial tertiary follicular organs. 2

  • Vascular smooth muscle cells and endothelial cells actively participate in the pathologic process, not merely serving as passive targets. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2012

Guideline

Giant Cell Arteritis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pathophysiology and Clinical Manifestations of Giant Cell Arteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.